Sanjivani Paranteral Ltd

Sanjiv.Parant. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Sanjivani Paranteral Ltd

₹ 265 2.91%
04 Mar 12:09 p.m.
sanjivani.co.in BSE: 531569
About

Incorporated in 1994, Sanjivani Paranteral
Ltd does manufacturing and export of pharmaceutical products[1]

Key Points

Business Overview:
Sanjivani Paranteral Ltd is a pharmaceutical company headquartered in Mumbai. It specializes in manufacturing and distribution of high-quality parenteral and oral solid products. It caters to major therapeutic areas encompassing CNS, CVS, Antibiotics, Gastroenterological, Anti-Diabetics and Anti-Allergic, supported by a strong R&D set-up.[1]

Website BSE
  • Market Cap ₹ 315 Cr.
  • Current Price ₹ 265
  • High / Low ₹ 397 / 122
  • Stock P/E 51.0
  • Book Value ₹
  • Dividend Yield 0.00 %
  • ROCE %
  • ROE %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Promoter holding is low: 27.7%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2023 Sep 2024 Dec 2024
14.96 18.13 17.35
12.99 15.28 14.80
Operating Profit 1.97 2.85 2.55
OPM % 13.17% 15.72% 14.70%
0.25 0.39 0.31
Interest 0.08 0.18 0.19
Depreciation 0.24 0.15 0.16
Profit before tax 1.90 2.91 2.51
Tax % 13.16% 21.31% 24.30%
1.65 2.30 1.90
EPS in Rs 1.65 1.97 1.60
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024
54.41
46.18
Operating Profit 8.23
OPM % 15.13%
0.52
Interest 0.25
Depreciation 0.93
Profit before tax 7.57
Tax % 18.63%
6.17
EPS in Rs 5.28
Dividend Payout % 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Stock Price CAGR
10 Years: 32%
5 Years: 97%
3 Years: 67%
1 Year: 51%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024
Equity Capital
Reserves
Total Liabilities
CWIP
Investments
Total Assets

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024
Net Cash Flow

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024
Debtor Days
Inventory Days
Days Payable
Cash Conversion Cycle
Working Capital Days
ROCE %

Shareholding Pattern

Numbers in percentages

1 Recently
Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
27.35% 27.35% 27.35% 27.35% 29.88% 31.70% 32.34% 32.34% 27.67% 27.67% 27.67% 27.67%
16.50% 16.50% 16.50% 16.50% 14.23% 11.89% 8.16% 6.01% 9.71% 9.36% 6.26% 6.26%
56.14% 56.14% 56.14% 56.14% 55.89% 56.40% 59.51% 61.65% 62.62% 62.98% 66.08% 66.09%
No. of Shareholders 4,9744,8484,8264,8454,8874,7584,5004,5004,9116,1666,7316,618

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls